1. Home
  2. Download Summary Company
New Try New Voice Based Search
×

Summary Of Pt Rubycon Indonesia

Download All File (.xls)

Company Name

Pt Rubycon Indonesia

Type Of Company

Trader

Employee Strength

--'

Key Management

Koichi Sato

Designation

Director

Contact Number

62-770-611412

Country

Indonesia

Region

Southeast Asia

Continent

Asia

Company URL

--

North America
Europe
Oceania
Africa
Asia
South America
Clinical Trial
Biosimilar

Summary of Pt Rubycon Indonesia

Chemxpert provides a high-level overview of Pt Rubycon Indonesia as a company group, covering its organizational structure, leadership, operational scale, and competitive landscape.

Basic Information

The Basic Information tab captures core details that help users quickly understand the size, structure, and business footprint of Pt Rubycon Indonesia.

  • Company Name: Official legal or commonly used company group name
  • Employee Strength: Total workforce size across the company group
  • Total Number of Subsidiaries: Count of subsidiary and affiliated entities
  • Key Management: Senior leadership responsible for strategic and operational decisions
  • Designation: Official roles held by key management members
  • Business Areas: Industry segments such as APIs, formulations, chemicals, and life sciences
  • Certifications: Regulatory and quality certifications held across the group
  • Manufacturing Locations: Number of manufacturing sites globally
  • Competitors / Peers: Companies operating in similar business segments

This basic company intelligence helps users establish organizational context before exploring detailed product, regulatory, and market data.

Business Areas – Product Presence of Pt Rubycon Indonesia

This section provides a segment-wise view of Pt Rubycon Indonesia's product presence across the pharmaceutical, life sciences, and chemical ecosystem.

For each business area, Chemxpert captures the number of products associated with the company group, helping users understand its breadth of operations, strategic focus areas, and diversification level.

Industry Segments Covered

  • API – Small Molecules
  • Finished Dosage Forms (FDF)
  • Pharma Intermediates
  • Fine & Specialty Chemicals
  • Excipients
  • Cosmetic Ingredients
  • Food Industry Ingredients
  • Polymers
  • Flavors & Fragrances
  • Veterinary Actives
  • Impurities & Metabolites
  • Nutraceuticals & Dietary Supplements
  • Clinical Trial Products
  • API – Biologics & Biosimilars
  • Essential Oils
  • Dye Intermediates
  • Isotopes
  • Vaccines
  • Diagnostics & Radiopharmaceuticals
  • Chemical Intermediates

This segment-level visibility helps users assess diversification, specialization, and strategic positioning across the life sciences value chain.

Product Portfolio – Supplied by Pt Rubycon Indonesia

This section provides detailed visibility into the products supplied by Pt Rubycon Indonesia and its group entities across global pharmaceutical markets.

The data focuses on what the company manufactures and supplies to customers, helping users evaluate its commercial offerings, regulatory readiness, and supply reach.

Supplying Products – Active Ingredients (APIs)

This dataset includes detailed information on active pharmaceutical ingredients supplied by Pt Rubycon Indonesia to different countries.

It covers:

  • API names and classifications
  • Countries where the APIs are supplied
  • Regulatory and market presence associated with each API

This information supports sourcing decisions, supplier evaluation, and market access assessment.

Supplier Certifications

Captures regulatory and quality certifications held by supplying entities within the company group.

Supplying Contact Information

Verified business contact details enabling commercial, regulatory, and sourcing communication.

Supplying Products – Finished Dosage Forms (FDF)

Provides information on finished dosage forms supplied across global markets.

Subsidiaries & Affiliates of Pt Rubycon Indonesia

Details subsidiary companies and affiliated entities operating under the company group structure.

Manufacturing Locations

Outlines the global manufacturing footprint by certification type.

  • US FDA, EU-GMP, UK MHRA, Japan PMDA
  • Canada, Korea FDA, Brazil ANVISA
  • Australia & New Zealand
  • India CDSCO, WHO-GMP, PIC/S

Certifications & Accreditations

  • US FDA, EDQM / EMA / EU-GMP
  • PMDA (Japan), TGA (Australia)
  • WHO-GMP / cGMP, MHRA (UK)
  • US-DMF, CEP / COS
  • Other regional and functional certifications

Competitors / Peers

Provides competitive benchmarking across product segments including APIs, FDFs, intermediates, nutraceuticals, diagnostics, vaccines, and more.

Financials

Captures financial performance over the last three years, including annual reports and disclosures to evaluate financial stability and long-term supplier viability.

Patent Filed

  • US patent expiry and exclusivity
  • SPCs and Paragraph IV filings
  • Off-patent products with no generics
  • Pharma patent disputes
  • Canada data protection and patent expiry
  • India drug patents granted
  • Korea patent expiry data

Warning Letters by Authority

  • US FDA warnings, Form 483, recalls, inspections
  • EU monitoring lists
  • India CDSCO banned drugs and NPPA actions
  • WHO essential drug listings
  • NLEM, Orphan Drug, BTA / FTA status

Pipeline Products

  • Products in clinical trials
  • Products under development or pre-commercial stages

Recent News

  • Product launches and approvals
  • Certifications and accreditations
  • Clinical trial updates
  • Licensing, partnerships, mergers, acquisitions
  • Regulatory warnings or recalls

Get detailed business insights of Pt Rubycon Indonesia – Click here

Why Choose Chemxpert?

  • Access molecule-level and company-group intelligence
  • Reduce due-diligence time and sourcing risk
  • Make faster, data-backed strategic decisions

Discover the full Chemxpert dataset and start analyzing with the right data to make the right decisions.